Skip to main content
Finanzoo GmbH Finanzoo GmbH

Azenta Value Stock - Dividend - Research Selection

Brooks automation

ISIN: US1143401024 , WKN: 257275
Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.


Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet

Description of the company

Brooks Automation, Inc. provides automation and cryogenic solutions for various applications and markets. It operates in two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum, and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; automated cleaning and inspection systems for wafer carriers, as well as reticle pod cleaners and stockers; and vacuum pumping and thermal management solutions for critical process vacuum applications. This segment also offers repair, diagnostic, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates, and foils; and instruments used for labeling, bar coding, capping, decapping, auditing, sealing, peeling, and piercing tubes and plates. It also provides sample management services, such as on-site and off-site sample storage, cold chain logistics, sample relocation, bio-processing, disaster recovery, and business continuity, as well as project management and consulting. In addition, this segment offers sample intelligence software solutions and customer technology integration; and laboratory work flow scheduling for life science tools and instrument work cells, sample inventory and logistics, environmental and temperature monitoring, and clinical trial and consent management, as well as planning, data management, virtualization, and visualization services. The company serves semiconductor capital equipment and sample management markets for life sciences in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,

NEWS


Insider Buying Highlights 3 Undervalued Small Caps Across Regions

2025-09-16
As the Nasdaq and S&P 500 reach record highs, driven by optimism surrounding potential Federal Reserve interest rate cuts, small-cap stocks in the United States are garnering increased attention. In this dynamic market environment, identifying promising opportunities often involves examining key indicators such as insider buying activity and valuation metrics to uncover potentially undervalued small-cap companies poised for growth.
Yahoo

Here’s What Pressured Azenta (AZTA) in Q2

2025-09-02
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net return of +9.6% compared to a total return of +8.5% for the long-only small-cap Russell 2000 Index (the “Russell”), and a total return […]
Yahoo

Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2

2025-08-26
Let’s dig into the relative performance of Azenta (NASDAQ:AZTA) and its peers as we unravel the now-completed Q2 drug development inputs & services earnings season.
Yahoo

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

2025-08-22
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospe
Yahoo

3 Reasons to Avoid AZTA and 1 Stock to Buy Instead

2025-08-21
What a brutal six months it’s been for Azenta. The stock has dropped 33.5% and now trades at $29.77, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Yahoo

Exploring 3 Undervalued Small Caps With Insider Action In Your Region

2025-08-18
As the U.S. market navigates a landscape marked by record highs for the Dow Jones Industrial Average and mixed performances from other indices like the S&P 500, small-cap stocks remain an intriguing area of focus, especially amid ongoing discussions about potential interest rate cuts by the Federal Reserve. In this dynamic environment, identifying promising small-cap opportunities often involves looking at companies with strong fundamentals and recent insider activity, which can signal...
Yahoo

Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know

2025-08-13
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth
Yahoo

The Top 5 Analyst Questions From Azenta’s Q2 Earnings Call

2025-08-13
Azenta’s Q2 results were met with a significant negative market reaction following a flat sales performance that missed Wall Street’s revenue expectations. Management attributed the lack of growth to persistent macroeconomic pressures and delayed customer purchasing decisions, particularly in its core product lines. CEO John Marotta described the environment as one of "funding constraints, supply chain complexities or market uncertainties," with growth primarily coming from next-generation seque
Yahoo

AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter

2025-08-13
Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year on year at $143.9 million. Its non-GAAP profit of $0.14 per share was in line with analysts’ consensus estimates.
Yahoo

Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know

2025-08-12
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower inte
Yahoo